SCARB2 and focal segmental glomerulosclerosis: Rood et al. [52] analysed urine samples in a small cohort of 5 MN patients and discovered LIMP-2 peptides (p < 0.01), a potential biomarker for Idiopathic MN compared to healthy controls and FSGS patients.